Artal Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Artal Group’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$566K	Buy
2018 Q1	–	Sell
2017 Q4	$2.46M	Sell
2017 Q3	$3.41M	Sell
2017 Q2	$4.73M	Buy
2017 Q1	$4.2M	Buy